Pluristem Therapeutics Inc (PSTI)

[zzaatt]

Based on our results of a reduction of postoperative stress by PLX-PAD, the indication has been adapted to hip fracture patients, who suffer even more due to the surgery-induced stress of hip arthroplasty. In addition, we included in the Phase III study endpoints which measure the systemic effect of PLX-PAD, which we observed in the earlier study, such as increase of contralateral gluteal muscle force and pro-regenerative immunological changes.

Taken together, we believe the Phase III study design greatly supports the likelihood of its success

From Dr.Winkler!

Let's see: Dr.Winkler VS "AutoEich", addressing the therapeutic MOA and markers and clinical benefit of PLX-PAD.
And the winner is..... LOL!